$48.00

-0.23 (-0.48%)

Weekly Expected Move ±7.1%

$40 $43 $47 $50 $53

NYSE · Healthcare · Medical - Distribution · Alpha Radar Strong Sell · Power 30 · $2.3B mcap · 47M float · 1.29% daily turnover · Short 40% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$1.1B -4.3% ▼

5Y CAGR: +2.9%

Gross Profit

$575M -9.4% ▼

5Y CAGR: +1.0%

Operating Income

$309M -8.1% ▼

5Y CAGR: +0.8%

Net Income

$190M -11.3% ▼

5Y CAGR: +2.9%

EPS (Diluted)

$3.91 -8.9% ▼

5Y CAGR: +3.8%

EBITDA

$341M -5.9% ▼

5Y CAGR: +1.5%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$1.1B	$1.1B	$1.1B	$1.1B	$1.1B
YoY Growth	+15.2%	+3.8%	-0.2%	+1.1%	-4.3%
Cost of Revenue	$466M	$502M	$501M	$503M	$514M
Gross Profit	$621M	$625M	$624M	$634M	$575M
Gross Margin	57.1%	55.4%	55.5%	55.8%	52.8%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$265M	$252M	$259M	$264M	$265M
Operating Expenses	$291M	$648M	$282M	$298M	$265M
Operating Income	$330M	-$22M	$342M	$337M	$309M
Operating Margin	30.4%	-2.0%	30.4%	29.6%	28.4%
Interest Expense	$64M	$69M	$67M	$48M	$42M
Income Before Tax	$262M	-$94M	$276M	$284M	$257M
Tax Expense	$57M	-$12M	$67M	$70M	$67M
Net Income	$205M	-$82M	$209M	$215M	$190M
Net Margin	18.9%	-7.3%	18.6%	18.9%	17.5%
EPS (Diluted)	$4.04	$-1.65	$4.17	$4.29	$3.91
EBITDA	$359M	$8M	$374M	$362M	$341M
Shares Outstanding	51M	50M	50M	50M	49M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$283M	$277M	$267M	$284M	$290M	$297M	$250M	$274M
Cost of Revenue	$125M	$125M	$121M	$126M	$129M	$121M	$114M	$120M
Gross Profit	$158M	$152M	$146M	$157M	$161M	$176M	$135M	$154M
Gross Margin	55.9%	54.8%	54.7%	55.5%	55.5%	59.2%	54.2%	56.2%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$65M	$64M	$68M	$67M	$64M	$64M	$63M	$67M
Operating Expenses	$71M	$70M	$74M	$73M	$69M	$87M	$63M	$74M
Operating Income	$87M	$82M	$72M	$84M	$92M	$88M	$72M	$80M
Operating Margin	30.7%	29.7%	27.0%	29.7%	31.7%	29.8%	28.8%	29.1%
Interest Expense	$17M	$15M	$13M	$12M	$11M	$11M	$10M	$10M
Income Before Tax	$70M	$67M	$58M	$72M	$80M	$74M	$62M	$69M
Tax Expense	$17M	$18M	$9M	$17M	$19M	$24M	$14M	$27M
Net Income	$53M	$49M	$49M	$54M	$61M	$50M	$47M	$42M
Net Margin	18.8%	17.9%	18.4%	19.2%	21.0%	16.9%	19.0%	15.4%
EPS (Diluted)	$1.06	$0.98	$0.98	$1.09	$1.22	$1.00	$0.95	$0.86
EBITDA	$94M	$90M	$80M	$90M	$98M	$92M	$80M	$87M
Shares Outstanding	50M	50M	50M	50M	50M	50M	50M	49M

PBH NYSE